Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 32 Carcinoma, Non-Small-Cell Lung 29 Neoplasms 26 Head and Neck Neoplasms 26 Colonic Neoplasms 20 Neoplasm Metastasis 17 Rectal Neoplasms 12 Breast Neoplasms 11 Lung Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Squamous Cell 6 Tongue Neoplasms 5 Salivary Gland Neoplasms 5 Melanoma 5 Stomach Neoplasms 4 Solid Tumors 4 Ovarian Neoplasms 4 Carcinoma, Renal Cell 4 Advanced Solid Tumor 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Kidney Neoplasms 3 Endometrial Neoplasms 3 Advanced Cancers 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Recurrence 2 Pharyngeal Neoplasms 2 Neoplasms by Site 2

Interventions

pembrolizumab 3 Cyclophosphamide 3 fludarabine 2 Rosuvastatin Calcium 2 Radiotherapy 2 Paclitaxel 2 Ipilimumab 2 Interleukin-2 2 Carboplatin 2 spartalizumab 1 peposertib 1 osimertinib 1 niraparib 1 neotil 1 necitumumab 1 mirdametinib 1 apatinib 1 amivantamab 1 Valganciclovir 1 Tomography, X-Ray Computed 1 Rifampin 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Midazolam 1 Metformin 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor, Adult × Cetuximab × Clear all

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡